• Explore /
  • Poster
  • / Induction mFOLFOX6 with or without aflibercept followed by chemoradiation (CRT) and surgery in high risk rectal cancer: Phase II randomized, multicenter, openlabel trial—The GEMCAD RIA study.

Induction mFOLFOX6 with or without aflibercept followed by chemoradiation (CRT) and surgery in high risk rectal cancer: Phase II randomized, multicenter, openlabel trial—The GEMCAD RIA study.

Abstract Poster

Authors

null

Carlos Fernandez-Martos

Instituto Valenciano de Oncologia, Valencia, Spain

Carlos Fernandez-Martos , Vicente Alonso , Isabel Busquier , Jaume Capdevila , Antonio Cubillo Gracian , Javier Gallego Plazas , Inmaculada Guasch , Laura Layos , Ferran Losa , Juan Maurel , Marta Martin-Richard , Mercedes Martinez Villacampa , Bartomeu Massuti , Clara Montagut Viladot , Miquel Nogue , Carles Pericay , Maria Jose Safont , Nuria Salas , Antonieta Salud Salvia , Ruth Vera

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Colorectal) Cancer

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer

Clinical Trial Registration Number

02340949

Citation

J Clin Oncol 33, 2015 (suppl; abstr TPS3626)

DOI

10.1200/jco.2015.33.15_suppl.tps3626

Abstract #

TPS3626

Poster Bd #

116a

Abstract Disclosures

Similar Posters

First Author: Carlos Fernandez-Martos

First Author: Carlos Fernandez-Martos

First Author: Darren Cowzer

First Author: Peter Acs